Validation of a Negative Regulator as a Novel Therapy for Autoimmune Disease
IMMUNEXT PHARMACEUTICALS · Department of Health and Human Services
Phase I2012$600,000
DESCRIPTION (provided by applicant): The immune system depends upon an exquisite balance between positive and negative signals to maintain proper function. However, disruptions of this balance can lead to inappropriate…